CTLA4 and neoplasm: Immune checkpoint inhibitors, such as PD-1/PD-L1 inhibitors and CTLA-4 inhibitors, is a way to remove tumor cells from the inhibitory effect of tumor cells on the immune system, release immune responses, and eliminate tumor cells, which are the excellent content of immunotherapy for colorectal cancer.